Dr. Qinlong Zheng

Dr. Qinlong Zheng is a highly experienced physician with 35 years of oncology, hematology, molecular biology, and human genetics expertise. He has held key positions at prestigious institutions such as the University of Oklahoma Health Medicine Center, the American Cancer Institute, and the Oklahoma Medical Research Foundation in the United States. Dr. Zheng is currently the Head of the Nordic International Biochemical Pathology Research Center and is a researcher and director of the molecular diagnostics laboratory at the Beijing GoBroad Boren Hospital in China. His impressive background in research and leadership roles highlights his dedication to advancing healthcare through innovative molecular diagnostics and cutting-edge treatments. With a Ph. D. in cell and molecular biology and a master's degree in pediatric hematology, Dr. Zheng's unique expertise allows him to offer specialized care in diagnosing and treating complex medical conditions. His focus on oncology and hematology underscores his commitment to improving patient outcomes and developing new approaches to cancer treatment. Dr. Zheng's leadership in molecular diagnostics showcases his ability to translate scientific research into clinical practice, ultimately benefiting patients with accurate diagnoses and personalized treatment plans.